biosynthesi
nanoparticl
insid
aureu
cell
enhanc
sensit
immunoassay
base
aureu
nanoparticl
howev
current
method
limit
antigen
detect
conjug
igg
antibodi
aureu
nanoparticl
studi
simpl
way
conjug
antigen
aureu
nanobioparticl
develop
util
cell
wall
bind
domain
cbd
bacteriophag
lysin
base
novel
design
simpl
agglutin
test
igg
antibodi
ebola
viru
ebov
nucleoprotein
np
middl
east
respiratori
viru
mer
np
rabbit
sera
success
develop
conjug
aureu
nanobioparticl
two
fusion
protein
ebov
npcbd
mer
npcbd
respect
conjug
done
easili
mix
fusion
protein
aureu
nanoparticl
detect
time
within
min
without
special
equip
expertis
far
know
first
time
realiz
detect
viral
antibodi
base
aureu
nanoparticl
recent
year
emerg
field
bionanotechnolog
synthesi
nanomateri
live
organ
yeast
fungi
bacteria
demonstr
great
potenti
differ
applic
among
bacteria
protein
produc
aureu
attract
vector
immunoassay
pathogen
especi
coagglutin
test
bacteria
virus
easi
conjug
igg
antibodi
protein
molecul
surfac
aureu
cell
time
biosynthesi
nanoparticl
insid
aureu
cell
could
exploit
enhanc
detect
sensit
exampl
biosynthesi
quantum
dot
insid
aureu
cell
use
sensit
detect
viru
lab
establish
simpl
way
transform
aureu
red
fluoresc
nanobioprob
react
monotetrazolium
redox
dye
tetrazolium
chlorid
ctc
room
temperatur
compar
uncolor
aureu
nanobioprob
fold
higher
sensit
achiev
rapid
coagglutin
test
e
coli
novel
red
nanobioprob
despit
tremend
progress
made
area
current
method
still
limit
antigen
detect
conjug
igg
antibodi
aureu
nanoparticl
studi
aim
present
simpl
way
conjug
antigen
aureu
nanobioparticl
util
cell
wall
bind
domain
cbd
bacteriophag
lysin
could
bind
surfac
aureu
nanobioparticl
base
novel
design
simpl
agglutin
test
igg
antibodi
ebola
viru
ebov
nucleoprotein
np
middl
east
respiratori
syndrom
coronaviru
merscov
np
success
develop
conjug
aureu
nanobioparticl
two
fusion
protein
ebov
npcbd
mer
npcbd
ebov
merscov
highli
contagi
pathogen
caus
ebola
viru
diseas
acut
respiratori
infecti
diseasemiddl
east
respiratori
syndrom
respect
specif
antivir
drug
vaccin
approv
clinic
use
ebov
merscov
rapid
specif
diagnosi
essenti
control
infect
gener
virusspecif
antibodi
igm
igg
rise
titer
constitut
strong
presumpt
detect
therefor
detect
igm
igg
antibodi
blood
use
commonli
epidem
investig
viral
infect
diagnost
method
enzymelink
immunosorb
assay
elisa
indirect
immunofluoresc
assay
ifa
neutral
test
protein
microarray
develop
ebov
merscov
antibodi
detect
howev
requir
dedic
instrument
limit
applic
assay
field
import
fast
respons
epidem
comparison
agglutin
test
rapid
inexpens
simpl
interpret
importantli
requir
special
instrument
sinc
nake
eye
could
read
result
therefor
agglutin
test
might
good
choic
ebov
merscov
antibodi
detect
field
agglutin
test
conjug
quit
simpl
could
done
easili
mix
fusion
protein
aureu
nanoparticl
far
know
first
time
realiz
detect
viral
antibodi
base
aureu
nanoparticl
monoclon
antibodi
clone
specif
ebov
subtyp
zair
np
develop
lab
previous
polyclon
rabbit
antisera
ebov
subtyp
zair
np
mer
viru
np
kindli
provid
professor
zhengli
shi
wuhan
institut
virolog
chines
academi
scienc
determin
antibodi
titer
monoclon
antibodi
polyclon
rabbit
antiserum
ebov
subtyp
zair
np
elisa
elisa
perform
describ
nakayama
et
al
use
recombin
np
antigen
briefli
elisa
plate
coat
predetermin
optim
quantiti
recombin
ebov
subtyp
zair
np
antigen
ngwell
purifi
monoclon
antibodi
clone
polyclon
rabbit
antiserum
dilut
seri
fold
pb
contain
bsa
ad
well
incub
coat
np
antigen
min
c
respect
wash
bound
monoclon
antibodi
clone
polyclon
rabbit
antiserum
detect
use
horseradish
peroxidas
hrp
conjug
rabbit
antimous
igg
goat
antirabbit
igg
dilut
respect
final
optic
densiti
od
measur
nm
use
micropl
reader
synergi
biotek
usa
dilut
test
triplic
fusion
protein
ebov
npcbd
construct
follow
ebov
np
gene
amplifi
np
primer
ebov
npcbdf
ebov
restrict
endonucleas
site
ital
digest
nhe
ecor
subsequ
digest
fragment
insert
plasmid
g
ebov
cbd
digest
nhe
ecor
yield
plasmid
np
g
cbd
express
vector
np
cbd
fusion
protein
mer
npcbd
construct
way
clone
plasmid
transform
ecoli
compet
cell
histidin
tag
ebov
npcbd
mer
npcbd
express
ecoli
purifi
nickelchel
affin
chromatographi
puriti
elut
ebov
npcbd
mer
npcbd
confirm
sdspage
concentr
ebov
npcbd
mer
npcbd
dialysi
determin
bicinchonin
acid
bca
kit
bi
yun
tian
biotechnolog
inc
china
aureu
nanobioparticl
prepar
aureu
strain
cctcc
briefli
aureu
cell
grown
ml
luriabertani
broth
master
seed
incub
c
h
ml
cultur
transfer
ml
luriabertani
broth
incub
c
reach
cell
harvest
centrifug
rpm
min
wash
twice
phosphat
buffer
salin
pb
ph
follow
addit
mm
ctc
cultur
cell
kept
c
h
subsequ
red
color
cell
harvest
centrifug
rpm
min
wash
thrice
pb
final
cell
heat
treat
c
min
water
bath
complet
inactiv
nanobioparticl
obtain
store
c
use
prepar
aureu
nanobioparticl
use
agglutin
test
mer
np
igg
antibodi
similar
method
except
aureu
cell
stain
anoth
tetrazolium
redox
dye
triphenyl
tetrazolium
chlorid
ttc
instead
ctc
aureu
nanobioparticl
sensit
fusion
protein
ebov
npcbd
detect
igg
antibodi
ebov
np
briefli
suspens
ml
aureu
nanoparticl
prepar
mix
g
ebov
npcbd
mixtur
incub
c
half
hour
shaker
rpm
nanobioprob
obtain
wash
pb
ph
centrifug
resuspend
pb
concentr
wv
sodium
azid
ad
final
concentr
nanobioprob
suspens
store
c
use
test
polyclon
rabbit
antiserum
inactiv
c
min
agglutin
test
l
dilut
polyclon
rabbit
antiserum
dilut
mab
mix
equal
volum
nanobioprob
sensit
ebov
npcbd
vbottom
plate
mixtur
incub
c
mix
thoroughli
everi
two
minut
blank
control
reaction
simultan
made
mix
l
nanobioprob
suspens
l
pb
sampl
consid
posit
appear
obviou
agglutin
blank
control
show
agglutin
nake
eye
within
min
reaction
among
igg
moleucl
protein
surfac
one
staphylococc
particl
antigen
molecul
fuse
cbd
anoth
particl
demonstr
igg
antibodi
mer
np
sandwich
protein
surfac
one
staphylococc
particl
via
fc
fragment
mer
npcbd
fuse
anoth
particl
agglutin
two
type
aureu
nanobioparticl
one
sensit
mer
npcbd
nonsensit
use
first
l
nonsensit
aureu
nanoparticl
mix
l
mer
np
polyclon
rabbit
antiserum
incub
c
hour
mixtur
centrifug
rpm
min
remov
unbound
antibodi
harvest
particl
prereact
igg
antibodi
prereact
particl
wash
thrice
pb
resuspend
l
pb
final
l
mer
npcbd
sensit
aureu
nanobioparticl
mix
l
prereact
aureu
nanoparticl
microscop
slide
mixtur
incub
room
temperatur
mix
thoroughli
everi
two
minut
neg
control
simultan
made
mix
l
nonsensit
aureu
nanobioparticl
l
nanoparticl
prereact
igg
antibodi
agglutin
test
igg
antibodi
mer
np
aureu
nanobioparticl
sensit
fusion
protein
mer
npcbd
similar
way
prepar
ebov
np
sensit
aureu
nanobioparticl
agglutin
test
l
mer
np
polyclon
rabbit
antiserum
mix
ul
nanobioprob
sensit
mer
npcbd
microscop
slide
mixtur
incub
room
temperatur
mix
thoroughli
everi
two
minut
blank
control
neg
control
simultan
made
mix
l
pb
neg
rabbit
serum
respect
l
nanobioprob
suspens
thirti
seven
hcv
posit
sera
serum
suspect
case
influenzalik
symptom
use
test
nonspecif
agglutin
sera
firstli
inactiv
heat
c
hour
dilut
time
use
pb
test
specif
test
perform
mix
l
dilut
serum
equal
volum
nanobioprob
sensit
ebov
npcbd
mixtur
incub
c
mix
thoroughli
everi
two
minut
agglutin
min
observ
suspens
nanobioprob
sensit
ebov
npcbd
store
c
month
storag
end
week
agglutin
test
perform
shown
fig
detect
igg
antibodi
ebov
np
color
aureu
nanoparticl
sensit
fusion
protein
ebov
npcbd
via
bind
cbd
surfac
presenc
igg
antibodi
ebov
np
igg
antibodi
could
bind
protein
surfac
staphylococc
particl
via
fc
fragment
leav
antigen
bind
domain
attach
np
staphylococc
particl
lead
agglutin
suspens
ml
aureu
nanoparticl
sensit
g
fusion
protein
ebov
npcbd
ebov
np
cbd
respect
sensit
nanobioprob
incub
equal
volum
mab
dilut
respect
vbottom
plate
shown
fig
ebov
npcbd
sensit
nanobioprob
appear
obviou
agglutin
ebov
np
cbd
sensit
nanobioprob
blank
control
show
agglutin
within
min
result
show
ebov
np
antigen
could
bind
surfac
aureu
nanoparticl
via
fusion
cbd
titer
monoclon
antibodi
polyclon
rabbit
antiserum
ebov
subtyp
zair
np
test
elisa
respect
polyclon
antibodi
ebov
np
dilut
seri
fold
pb
l
dilut
use
agglutin
test
shown
fig
highest
dilut
antibodi
agglutin
clearli
seen
min
ebov
posit
sera
unavail
order
simul
ebov
posit
sera
mab
specif
ebov
np
first
dilut
fold
human
serum
dilut
fold
pb
aliquot
l
dilut
use
agglutin
test
human
serum
without
spike
ebov
np
also
dilut
pb
neg
control
shown
fig
highest
dilut
antibodi
agglutin
could
clearli
seen
min
agglutin
could
seen
neg
control
sinc
mab
sampl
first
dilut
fold
human
serum
actual
dilut
factor
fig
result
show
ebov
np
igg
antibodi
human
serum
detect
success
agglutin
test
polyclon
antibodi
mer
np
neg
rabbit
serum
dilut
fold
use
agglutin
test
glass
slide
shown
fig
polyclon
rabbit
antiserum
sampl
appear
obviou
agglutin
blank
control
neg
control
show
agglutin
within
min
agglutin
due
reaction
among
igg
antibodi
mer
np
protein
surfac
one
staphylococc
particl
mer
npcbd
fuse
anoth
particl
shown
fig
mer
npcbd
sensit
aureu
nanobioparticl
mix
aureu
nanoparticl
prereact
polyclon
rabbit
antiserum
sampl
obviou
agglutin
could
observ
neg
control
show
agglutin
within
min
sinc
free
antibodi
mixtur
result
demonstr
agglutin
caus
reaction
among
igg
antibodi
mer
np
protein
surfac
one
staphylococc
particl
mer
npcbd
bound
anoth
particl
shown
fig
agglutin
could
observ
within
min
ebov
npcbd
sensit
nanobioprob
incub
clinic
sera
test
result
demonstr
nanobioprob
quit
specif
shown
fig
ebov
npcbd
sensit
nanobioprob
found
stabl
least
one
month
storag
c
detect
sensit
deterior
storag
studi
present
simpl
rapid
way
conjug
antigen
surfac
aureu
nanobioparticl
fuse
antigen
cbd
success
develop
agglutin
test
detect
igg
antibodi
ebov
np
mer
np
compar
previou
agglutin
test
base
latex
particl
detect
igg
antibodi
advantag
use
present
method
first
physic
adsorpt
chemic
crosslink
normal
use
sensit
latex
particl
antigen
antigen
molecul
randomli
immobil
surfac
latex
particl
could
affect
subsequ
antigenantibodi
bind
reaction
current
method
antigen
molecul
immobil
aureu
particl
via
cbd
fuse
make
sure
antigen
molecul
good
orient
react
antibodi
therefor
current
method
could
provid
better
control
antigen
activ
previou
method
detect
antibodi
second
detect
antibodi
latex
agglutin
two
antigen
bind
site
igg
molecul
need
react
one
antigen
molecul
one
particl
anoth
antigen
molecul
anoth
particl
order
form
agglutin
might
difficult
sinc
antigen
molecul
particl
compet
attach
two
antigen
bind
site
igg
molecul
howev
current
method
competit
exist
sinc
igg
moleucl
could
bind
protein
surfac
one
staphylococc
particl
via
fc
fragment
bind
antigen
molecul
anoth
particl
via
fab
form
agglutin
fig
fig
new
agglutin
mode
could
lead
higher
detect
sensit
theori
actual
far
know
first
time
aureu
nanoparticl
use
agglutin
test
detect
antibodi
lastli
aureu
nanoparticl
biolog
synthes
mani
biomolecul
surfac
could
util
attach
differ
molecul
provid
new
possibl
sensit
lysin
produc
bacteriophag
digest
bacteri
cell
wall
releas
progeni
virion
consid
effect
antiinfect
agent
control
gramposit
bacteria
normal
c
terminu
lysin
cell
wall
bind
domain
cbd
specif
attach
host
cell
high
affin
current
studi
cbd
phage
lysin
util
conjug
antigen
simpl
mix
incub
step
success
sensit
aureu
nanoparticl
ebov
np
mer
np
indic
strategi
via
cbd
might
use
wide
antigen
fig
show
nonspecif
agglutin
caus
hcv
posit
sera
suspect
influenza
viru
serum
demonstr
good
select
method
sensit
antibodi
agglutin
test
lower
elisa
highest
dilut
monoclon
antibodi
polyclon
rabbit
antiserum
antibodi
ebov
subtyp
zair
np
respect
agglutin
could
clearli
seen
min
fig
antibodi
titer
antibodi
polyclon
rabbit
antiserum
test
elisa
respect
howev
due
simplic
rapid
good
stabil
need
instrument
read
result
antibodi
agglutin
test
base
multifunct
aureu
nanobioprob
could
good
potenti
real
applic
field
conclus
simpl
way
conjug
antigen
aureu
nanobioparticl
develop
util
cell
wall
bind
domain
cbd
bacteriophag
lysin
base
novel
design
simpl
agglutin
test
antibodi
could
develop
without
special
instrument
expertis
